Tayahop, Renita T.
HRN: 22-50-21 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/31/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
01/31/2023
02/07/2023
IV
4.5gram
Q6hrs
Septicemia
Waiting Final Action
Indication: Empiric Type of Infection: PneumoniaBloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes